콘텐츠로 건너뛰기
Merck
  • Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice.

Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice.

The Journal of pathology (2004-04-20)
Shin-Chung Kang, David R Brown, Matthew Whiteman, Ruliang Li, Tao Pan, George Perry, Thomas Wisniewski, Man-Sun Sy, Boon-Seng Wong
초록

Although the key event in the pathology of prion diseases is thought to be the conversion of cellular prion protein (PrP(C)) to the protease-resistant scrapie species termed PrP(Sc), the factors that contribute to neurodegeneration in scrapie-infected animals are poorly understood. One probable determinant could be when the accumulation of PrP(Sc) in infected brain overwhelms the ubiquitin-proteasome system and triggers the degenerative cascade. In the present study, it was found that in mouse brains infected with the ME7 scrapie strain, the level of ubiquitin protein conjugates increased significantly at approximately 144 days post-infection (pi) when clinical signs first become apparent. This elevation correlated with the detection of protease-resistant PrP(Sc) and a decline in two endopeptidase activities associated with proteasome function. However, ubiquitination of PrP was only detected at the terminal stage, 3 weeks after the development of clinical symptoms (approximately 165 days pi). These results suggest that ubiquitination of PrP is a late event phenomenon and this conjugation occurs after the formation of protease-resistant PrP(Sc). Whether this post-translational modification and the impairment of proteasome function are pivotal events in the pathogenesis of prion diseases remains to be determined.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Ubiquitin−Agarose, saline suspension